Methods: IH, IP, WB
Formulation: liquid, IgG fraction
Reacts in: Human
p35, co precipitates Cdk5
No Available References
- The Plot Thickens: The Complicated Relationship of Tau and Aβ
- Australia Report: Lessons From a Clinical Trial—Too Little Too Late
- Stockholm: Could a Whiff of NAP Nip Brain Inflammation in the Bud?
- Vienna (and Burkina Faso): What's New With Methylene Blue?
- Tau’s Synaptic Hats: Regulating Activity, Disrupting Communication
- Indianapolis: Clinical Trials a Ripple, Scientists Hope for a Wave
- Chicago: Trial Design Bedevils Search for New AD Drugs, Part 1
- Uppsala: Is Tau Immunotherapy Taking Off?